Efficacy and Safety of Subcutaneous Belimumab in Anti –Double‐Stranded DNA–Positive, Hypocomplementemic Patients With Systemic Lupus Erythematosus
Arthritis&Rheumatology,Volume 70, Issue 8, Page 1256-1264, August 2018.
Source: Arthritis and Rheumatology - Category: Rheumatology Authors: A. Doria MD
,
W. Stohl MD, PhD
,
A. Schwarting MD, PhD
,
M. Okada MD
,
M. Scheinberg MD, PhD
,
R. van Vollenhoven MD, PhD
,
A. E. Hammer BS
,
J. Groark MD
,
D. Bass DO, FACR
,
N. L. Fox PhD
,
D. Roth MD
,
D. Gordon MB, ChB Source Type: research